Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant ...
The collagen-based REGENETEN Bioinductive Implant stimulates the body's natural healing response by inducing the growth of new tendon-like tissue to biologically augment the existing tendon and ...
Smith & Nephew Snats ((SNN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Use of a bioinductive, bovine collagen implant may be safe and effective in the treatment of ...